We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants

Delisted

KTOVW was delisted on the 23rd of November, 2020.

2 hedge funds and large institutions have $16K invested in Kitov Pharma Ltd. Warrants in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 12 (+1)

33% more capital invested

Capital invested by funds: $12K → $16K (+$4K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.45K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.37K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$14K -$4.37K -7,864 -28%
UBS Group
2
UBS Group
Switzerland
$2K +$1.45K +2,600 New

KTOVW Hedge Fund Activity: Q3 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q3 2017, worth a combined $16K — up 33% from $12K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new KTOVW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $1.45K. The largest seller was Susquehanna International Group, cutting an estimated $4.37K.

  • 2 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q3 2017, up from 1 in Q2 2017.
  • Funds reported $16K of Kitov Pharma Ltd. Warrants stock for Q3 2017, up 33% quarter-over-quarter.
  • 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q3 2017 and 0 closed out, a net change of +1 holder.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q3 2017 was UBS Group, an estimated $1.45K added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q3 2017 was Susquehanna International Group, an estimated $4.37K sold.

Based on aggregated 13F filings for Q3 2017.